Durham, NC, February 4, 2025 – MedPharm, a global leader in topical and transdermal contract drug development and manufacturing, today announced the appointment of Bill Humphries as Chief Executive Officer. Bill’s leadership will enable MedPharm to accelerate its strategic growth following its merger with Tergus Pharma which significantly bolstered MedPharm’s scientific, clinical trial manufacturing, and […]

Guildford, UK and Durham, NC, February 20, 2024 – MedPharm, a global topical and transdermal CDMO, today announced several Board changes,

GUILDFORD, United Kingdom and DURHAM, N.C., July 8, 2024 — MedPharm, Ltd., an Ampersand Capital Partners portfolio company, and Tergus Pharma, a Great Point Partners portfolio company, jointly announced today a merger. The combined topical and transepithelial Contract Development and Manufacturing Organization (CDMO) will operate under the MedPharm name, establishing a leading, end-to-end CDMO with robust scientific, clinical trial manufacturing and […]

MedPharm, a global CDMO focused on topical and transdermal development and manufacturing, recently announced the appointment of a new U.S. Director

MedPharm, a global provider of contract topical and transdermal formulation development and manufacturing services,

MedPharm is pleased to announce that it has been selected as a finalist in two CPHI Pharma Award Categories.

MedPharm, a global Contract Development and Manufacturing Organization that specializes in topical and transdermal drug product development,